Atorvastatin therapy reduces vascular endothelial growth factor (VEGF) in patients with coronary artery disease

Hannes Alber; Jozef Dulak; Severin P. Schwarzacher; Otmar Pachinger; Franz Weidinger

doi:10.1016/s0021-9150(00)80868-0

Back

Atorvastatin therapy reduces vascular endothelial growth factor (VEGF) in patients with coronary artery disease

Article 2000 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2002

Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease

Hannes Alber, Jozef Dulak, Matthias Frick, Wolfgang Dichtl, Severin P. Schwarzacher, Otmar Pachinger, Franz Weidinger

Article2004

Mechanisms of disease: angiogenesis, vascular endothelial growth factor (VEGF) and psoriasis

Christopher Em Griffiths, Helen Young, Angela Summers, Paul Brenchley

Article2002

Vascular Endothelial Growth Factor (VEGF) in Ankylosing Spondylitis - a Pilot Study

C Goldberger, Jozef Dulak, Christina Duftner, Franz Weidinger, A. Falkenbach, Michael Schirmer

Article2004

Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration

Ludo Van Den Bosch, Erik Storkebaum, V. Vleminckx, Lieve Moons, Ludo Vanopdenbosch, Wendy Scheveneels, Peter Carmeliet, Wim Robberecht

Article2003

The effect of Vascular Endothelial Growth Factor (VEGF) on Motoneuron Degeneration

Ludo Van Den Bosch, Erik Storkebaum, V. Vleminckx, Lieve Moons, Ludo Vanopdenbosch, Wendy Scheveneels, Peter Carmeliet, Marc M. Van Hulle, Wim Robberecht